Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 6—June 2007

Minority-Variant pfcrt K76T Mutations and Chloroquine Resistance, Malawi

Jonathan J. Juliano*, Jesse J. Kwiek*, Kathryn Cappell*, Victor Mwapasa†, and Steven R Meshnick*Comments to Author 
Author affiliations: *University of North Carolina, Chapel Hill, North Carolina, USA; †University of Malawi, Blantyre, Malawi

Main Article

Table 1

Characteristics of patient samples*

Characteristic Value (range)
Age (y)
Total 21.9 (15–35)
MHP patients 23.7 (17–31)
MM patients 21.2 (15–35)
Parasite density (no. parasites/200 leukocytes)
Total 243.6 (4–2,202)
MHP patients 599.7 (4–2,202)
MM patients 83.3 (5–750)
Total 2.26 (1–9)
MHP patients 2.37 (1–3)
MM patients 2.21 (1–9)
Anemia (hemoglobin <11 g/dL)
Total 64/87 (73.6%)
MHP patients 21/27 (77.8%)
MM patients 43/60 (71.7%)
HIV status
Total† 38/58 (65.5%)
MHP patients 27/27 (100%)
MM patients 11/31 (35.5%)
Clinical symptoms‡
Fever 14/27 (51.8%)
Headache 18/27 (66.7%)
General body pain 13/27 (48.1%)
Preventive measures‡
Bed net use§ 6/19 (31.6%)

*MHP, Malaria and HIV in Pregnancy; MM, Mpemba and Madziabango.
†29 patients declined testing.
‡Data only available for MHP patients.
§No data available for 8 patients.

Main Article

Page created: May 31, 2011
Page updated: May 31, 2011
Page reviewed: May 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.